Research Topic

COVID-19 Infection in Cancer Patients: How Can We Help Patients and Oncologists? Vol II

About this Research Topic

The current global pandemic COVID-19 challenges oncologists to reorganise cancer care. Cancer patients are more susceptible to infections and likely to get severe consequences compared with other patients. What can help us cope with the emergency effort represented by the management of cancer patients in the COVID-19 era, today and in the future?

The aim of the Vol II of this Research Topic is to offer a platform on which to gather available data from the “frontlines”, as the availability of such data will prove crucial to policymakers and medical practitioners alike. Through this platform, we would like to invite managers of cancer centers to gather and report data for the benefit of those who encountered or will encounter this infection. In particular, we believe that the main road to elaborate meaningful scientific evidence is represented by the collection of all the data on COVID-19 and cancer comorbidity that are and will become available in cancer centers.

New potential questions include but are not limited to the following:
1) What are the practical limitations when a patient is found to be positive for COVID-19 (before or) after a session of chemotherapy, immunotherapy and/or targeted therapies?
2) How should fragile patients with advanced disease receiving chemotherapy be treated when they are in areas heavily affected by the infection? What ethical and practical implications can there be?
3) What vaccination priority strategies should there be in cancer patients?

Please note: Manuscripts consisting solely of bioinformatics, computational analysis, or predictions of public databases which are not accompanied by validation (independent cohort or biological validation in vitro or in vivo) will not be accepted in any of the sections of Frontiers in Oncology.


Keywords: COVID-19, Cancer, COVID-19 Vaccine, Oncologist


Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

The current global pandemic COVID-19 challenges oncologists to reorganise cancer care. Cancer patients are more susceptible to infections and likely to get severe consequences compared with other patients. What can help us cope with the emergency effort represented by the management of cancer patients in the COVID-19 era, today and in the future?

The aim of the Vol II of this Research Topic is to offer a platform on which to gather available data from the “frontlines”, as the availability of such data will prove crucial to policymakers and medical practitioners alike. Through this platform, we would like to invite managers of cancer centers to gather and report data for the benefit of those who encountered or will encounter this infection. In particular, we believe that the main road to elaborate meaningful scientific evidence is represented by the collection of all the data on COVID-19 and cancer comorbidity that are and will become available in cancer centers.

New potential questions include but are not limited to the following:
1) What are the practical limitations when a patient is found to be positive for COVID-19 (before or) after a session of chemotherapy, immunotherapy and/or targeted therapies?
2) How should fragile patients with advanced disease receiving chemotherapy be treated when they are in areas heavily affected by the infection? What ethical and practical implications can there be?
3) What vaccination priority strategies should there be in cancer patients?

Please note: Manuscripts consisting solely of bioinformatics, computational analysis, or predictions of public databases which are not accompanied by validation (independent cohort or biological validation in vitro or in vivo) will not be accepted in any of the sections of Frontiers in Oncology.


Keywords: COVID-19, Cancer, COVID-19 Vaccine, Oncologist


Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

About Frontiers Research Topics

With their unique mixes of varied contributions from Original Research to Review Articles, Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author.

Topic Editors

Loading..

Submission Deadlines

16 May 2021 Abstract
13 September 2021 Manuscript

Participating Journals

Manuscripts can be submitted to this Research Topic via the following journals:

Loading..

Topic Editors

Loading..

Submission Deadlines

16 May 2021 Abstract
13 September 2021 Manuscript

Participating Journals

Manuscripts can be submitted to this Research Topic via the following journals:

Loading..
Loading..

total views article views article downloads topic views

}
 
Top countries
Top referring sites
Loading..